Cohance Lifesciences
BSE 543064
4 stories, newest first.
- Central Government approves Umang Vohra as Chairman and Group CEO
- Grant of 2,60,194 options under ESOP 2026 and 6,14,594 options under ESOP 2023
- Abhimanyu Ojha appointed Chief Financial Officer and Key Managerial Personnel w.e.f. 12 October 2026
- Crisil assigns ESG rating of Crisil ESG 61 (Strong) and Core ESG 67 (Strong)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.